Read + Share
Amedeo Smart
Independent Medical Education
Zhou X, Zhou Y, Li X, Xiao X, et al. Safety concerns of SGLT-2 inhibitors in type 1 diabetes: a real-world study from the perspective of FAERS. Diabetes Obes Metab 2020 Jul 6. doi: 10.1111/dom.14138.PMID: 32633000
Email
LinkedIn
Facebook
Twitter
Privacy Policy